Concepedia

Publication | Open Access

A Phase I Study of the Combination of Rituximab and Ipilimumab in Patients with Relapsed/Refractory B-Cell Lymphoma

DOIFull Paper Access

47

Citations

19

References

2019

Year

Joseph M. Tuscano, Emanual Maverakis, Susan Groshen, Denice Tsao‐Wei, Guillaume Luxardi, Alexander A. Merleev, Anne Beaven, John F. DiPersio, Leslie Popplewell, Robert Chen,
Clinical Cancer Research

Abstract

The combination of R+I has manageable toxicity and encouraging efficacy in R/R follicular lymphoma. The ratio of CD45RA<sup>-</sup>Tregs to total Tregs, and peripheral BCD should be studied further as potential predictors of response.

References

YearCitations

Page 1